United States · FDA National Drug Code directory
Naproxen
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50228-435_9af8c9f3-92e7-4301-b401-f40230af2eb7
- Product NDC
- 50228-435
- Form
- TABLET
- Composition / generic term
- Naproxen
- Labeler
- ScieGen Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200301
- Source listing expiry
- 20271231
Source-listed ingredients
- NAPROXEN — 375 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (50228-435-01) · 50228-435-01
- 500 TABLET in 1 BOTTLE (50228-435-05) · 50228-435-05
- 1000 TABLET in 1 BOTTLE (50228-435-10) · 50228-435-10
- 30 TABLET in 1 BOTTLE (50228-435-30) · 50228-435-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →